Arovella Therapeutics Ltd (FRA:E4NA)
€ 0.0725 -0.0015 (-2.03%) Market Cap: 84.97 Mil Enterprise Value: 82.80 Mil PE Ratio: 0 PB Ratio: 43.33 GF Score: 41/100

Arovella Therapeutics Ltd Webinar Presentation Transcript

Jun 22, 2023 / 01:00AM GMT
Release Date Price: €0.0225 (-8.16%)
Operator

Presentation
Jun 22, 2023 / 01:00AM GMT

=====================
Corporate Participants
=====================
* Michael Baker
Arovella Therapeutics Limited - CEO & MD

=====================

Michael Baker
Arovella Therapeutics Limited - CEO & MD

Thank you for standing by, and welcome to the Arovella Therapeutics investor webinar and Q&A today. (Operator instructions) But appearing on behalf of the Arovella today, we have the CEO and Managing Director, Dr. Michael Baker. Michael, I'll hand it over to you.

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot